{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":67901,"items":[{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:50:25Z","timestamp":1756810225265},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":1011,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1093\/annonc\/mdx087.003","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T10:48:24Z","timestamp":1494240504000},"page":"ii6","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S2","title":["Domestic cooking fuel as a risk factor for lung cancer in women: A case control study"],"prefix":"10.1016","volume":"28","author":[{"given":"S.S.","family":"Katpattil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341933529X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341933529X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/28\/suppl_2\/mdx087.003\/16721500\/mdx087.003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T04:13:11Z","timestamp":1582171991000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341933529X"}},"issued":{"date-parts":[[2017,4]]},"references-count":0,"alternative-id":["S092375341933529X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdx087.003","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2017,4]]}},{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:47Z","timestamp":1756771247067,"version":"3.44.0"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.annonc.2024.08.706","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T16:08:03Z","timestamp":1726589283000},"page":"S507-S508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["639P Serial ctDNA profiling as a catalyst for tailored therapeutics in advanced cancer: Analysis of two precision medicine studies"],"prefix":"10.1016","volume":"35","author":[{"given":"S.","family":"Cousin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Belcaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L-J.","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bayle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Taleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Aldea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Alam\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Blouin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Soubeyran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hollebecque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Loriot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Besse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-C.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Barlesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Massard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753424022257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753424022257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T03:57:44Z","timestamp":1756699064000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753424022257"}},"issued":{"date-parts":[[2024,9]]},"references-count":0,"alternative-id":["S0923753424022257"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2024.08.706","ISSN":["0923-7534"],"issn-type":[{"type":"print","value":"0923-7534"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"639P Serial ctDNA profiling as a catalyst for tailored therapeutics in advanced cancer: Analysis of two precision medicine studies","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2024.08.706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:51:18Z","timestamp":1777697478992,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.annonc.2023.09.1899","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T08:31:35Z","timestamp":1697790695000},"page":"S493-S494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S2","title":["713TiP A phase I study of PRT3789, a potent and selective degrader of SMARCA2 in patients with advanced or metastatic solid tumors and a SMARCA4 mutation"],"prefix":"10.1016","volume":"34","author":[{"given":"I.","family":"Dagogo-Jack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dowlati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Swalduz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Moreno Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.A.","family":"Adjei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Punekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.A.","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tankersley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Paris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.I.","family":"Spira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Besse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753423027369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753423027369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T07:00:06Z","timestamp":1760338806000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753423027369"}},"issued":{"date-parts":[[2023,10]]},"references-count":0,"alternative-id":["S0923753423027369"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2023.09.1899","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"713TiP A phase I study of PRT3789, a potent and selective degrader of SMARCA2 in patients with advanced or metastatic solid tumors and a SMARCA4 mutation","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2023.09.1899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:06:33Z","timestamp":1720537593226},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":2688,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/s0923-7534(20)33669-3","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T18:11:00Z","timestamp":1578939060000},"page":"ix350","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S9","title":["Relationship between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia"],"prefix":"10.1016","volume":"23","author":[{"given":"C.","family":"Beauchemin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Aissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lachaine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420336693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420336693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T16:27:36Z","timestamp":1594398456000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420336693"}},"issued":{"date-parts":[[2012,9]]},"references-count":0,"alternative-id":["S0923753420336693"],"URL":"https:\/\/doi.org\/10.1016\/s0923-7534(20)33669-3","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2012,9]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:10:40Z","timestamp":1720537840748},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":1554,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s0923-7534(21)00652-9","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T20:43:02Z","timestamp":1614976982000},"page":"ix160","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S9","title":["494P Palliative care in Iran, two year experience of the Firoozgar Palliative Medicine Unit"],"prefix":"10.1016","volume":"27","author":[{"given":"R.","family":"Malayeri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hazini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pirjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Sharbafchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hojjat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753421006529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753421006529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T20:43:03Z","timestamp":1614976983000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753421006529"}},"issued":{"date-parts":[[2016,12]]},"references-count":0,"alternative-id":["S0923753421006529"],"URL":"https:\/\/doi.org\/10.1016\/s0923-7534(21)00652-9","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:10:41Z","timestamp":1720537841596},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":2688,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/s0923-7534(20)33312-3","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T18:01:09Z","timestamp":1578938469000},"page":"ix243","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S9","title":["Final Results of a Randomized Phase II Study of TSU-68 after Transarterial Chemoembolisation in Japanese Patients with Unresectable Hepatocellular Carcinoma.Chemoembolization"],"prefix":"10.1016","volume":"23","author":[{"given":"S.","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Yamakado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Imanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420333123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420333123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T16:17:41Z","timestamp":1594397861000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420333123"}},"issued":{"date-parts":[[2012,9]]},"references-count":0,"alternative-id":["S0923753420333123"],"URL":"https:\/\/doi.org\/10.1016\/s0923-7534(20)33312-3","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2012,9]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T15:07:53Z","timestamp":1720537673830},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T00:00:00Z","timestamp":1578700800000},"content-version":"vor","delay-in-days":2688,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/s0923-7534(20)32979-3","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T17:51:50Z","timestamp":1578937910000},"page":"ix144","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S9","title":["A Pilot Study Correlating IDH-1\/2 Gene Status with 2-Hydroxyglutarate (2HG) Concentration in Plasma and Urine from Patients (PTS) with Glioma"],"prefix":"10.1016","volume":"23","author":[{"given":"G.","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Corona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Farina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Zustovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bertorelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fiduccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. lla","family":"De Puppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Gardiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Salvalaggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Toffoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Zagonel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420329793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420329793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T16:08:29Z","timestamp":1594397309000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420329793"}},"issued":{"date-parts":[[2012,9]]},"references-count":0,"alternative-id":["S0923753420329793"],"URL":"https:\/\/doi.org\/10.1016\/s0923-7534(20)32979-3","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2012,9]]}},{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T05:56:50Z","timestamp":1722232610699},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":837,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1093\/annonc\/mdx424.043","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T09:12:34Z","timestamp":1509959554000},"page":"vi37","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S6","title":["Role of inflammation parameters in locally advanced breast cancer: the debate is still open"],"prefix":"10.1016","volume":"28","author":[{"given":"F.","family":"Merloni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pistelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Della Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bastianelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"De Lisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Burattini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Maccaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Ballatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Savini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pagliacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420347827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420347827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/28\/suppl_6\/mdx424.043\/21490557\/mdx424.043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T01:21:06Z","timestamp":1589246466000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420347827"}},"issued":{"date-parts":[[2017,10]]},"references-count":0,"alternative-id":["S0923753420347827"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdx424.043","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2017,10]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:21:52Z","timestamp":1720534912836},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":1773,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1093\/annonc\/mdv087.3","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T17:00:46Z","timestamp":1426870846000},"page":"ii13","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["No abstract available"],"prefix":"10.1016","volume":"26","member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420307274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420307274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/suppl_2\/ii13\/6675313\/mdv087.3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T03:22:56Z","timestamp":1582255376000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420307274"}},"issued":{"date-parts":[[2015,3]]},"references-count":0,"alternative-id":["S0923753420307274"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv087.3","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2015,3]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:20:57Z","timestamp":1720534857547},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":1893,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1093\/annonc\/mdu467.6","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T09:24:46Z","timestamp":1416561886000},"page":"vi3","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S6","title":["Influence of Tumor Necrosis Factor-Alpha-Thymosin-Alpha1 on the Humoral and Cellular Immunity of Patients with Locally Advanced Breast Cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"L.Y.","family":"Vladimirova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Podzorova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Zlatnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Zakora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bakhtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Myagkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419317338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419317338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/suppl_6\/vi4\/6674406\/mdu467.6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T08:36:01Z","timestamp":1582187761000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419317338"}},"issued":{"date-parts":[[2014,11]]},"references-count":0,"alternative-id":["S0923753419317338"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdu467.6","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2014,11]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:25:37Z","timestamp":1720535137200},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":2078,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1093\/annonc\/mdu067.2","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T06:05:20Z","timestamp":1398405920000},"page":"i17","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Lymphocytes Infiltrating Breast Cancer : Density, Composition and Organization"],"prefix":"10.1016","volume":"25","author":[{"given":"L.","family":"Buisseret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Garaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Duvillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Naveaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Duquenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"de Wind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vakili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sotiriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Willard-Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419643747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419643747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/suppl_1\/i17\/6674790\/mdu067.2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T01:15:23Z","timestamp":1589246123000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419643747"}},"issued":{"date-parts":[[2014,5]]},"references-count":0,"alternative-id":["S0923753419643747"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdu067.2","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:04:58Z","timestamp":1648739098216},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1996,8,1]],"date-time":"1996-08-01T00:00:00Z","timestamp":838857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":8559,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1996,8]]},"DOI":"10.1093\/oxfordjournals.annonc.a010669","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T21:46:43Z","timestamp":1334785603000},"page":"553-554","source":"Crossref","is-referenced-by-count":4,"title":["Radiotherapy and drugs: \u2018Setrons\u2019 once again"],"prefix":"10.1016","volume":"7","author":[{"given":"Matti S.","family":"Aapro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00003495-199142040-00002","article-title":"5-HT3 receptor antagonists: An overview of their present status and future potential in cancer therapy-induced emesis","volume":"42","author":"Aapro","year":"1991","journal-title":"Drugs"},{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199501053320101","article-title":"Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer","volume":"332","author":"The Italian group for anti-emetic research","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0015","series-title":"Serotonin and the Scientific Basis of Anti-Emetic Therapy","first-page":"181","article-title":"Does 5-HT play a role in the delayed phase of cisplatin-induced emesis?","author":"Gr\u00e9lot","year":"1995"},{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0020","first-page":"293","article-title":"Cost-benefit studies: The European perspective","volume":"2","author":"Aapro","year":"1994","journal-title":"Support Care Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0025","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bmj.311.7009.844","article-title":"Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: A review of published trials","volume":"311","author":"Aspinall","year":"1995","journal-title":"BMJ"},{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0030","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/oxfordjournals.annonc.a010675","article-title":"A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy","volume":"7","author":"Franz\u00e9n","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00874423","article-title":"Methodological issues in antiemetic studies","volume":"11","author":"Aapro","year":"1993","journal-title":"Invest New Drugs"},{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0040","first-page":"181","article-title":"Comparaison de l'ondans\u00e9tron et du granis\u00e9tron dans la pr\u00e9vention des naus\u00e9es et vomissements induits par le cisplatine: \u00c9tude multicentrique, randomis\u00e9e, en double-aveugle et groupes parall\u00e8les","volume":"2","author":"Groupe d'\u00c9tude des Antagonistes des R\u00e9cepteurs 5-HT3 (G.E.A.R.)","year":"1993","journal-title":"Cah Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a010669_bb0045","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/0959-8049(95)00208-Z","article-title":"Nausea and vomiting in fractionated radiotherapy: A prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide","volume":"31A","author":"Miralbell","year":"1995","journal-title":"Eur J Cancer"}],"container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419655262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419655262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/7\/6\/553\/480721\/7-6-553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T02:48:08Z","timestamp":1582253288000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419655262"}},"issued":{"date-parts":[[1996,8]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,8]]}},"alternative-id":["S0923753419655262"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a010669","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[1996,8]]}},{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T19:55:08Z","timestamp":1723319708404},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1093\/annonc\/mdq025","type":"journal-article","created":{"date-parts":[[2010,2,6]],"date-time":"2010-02-06T01:45:38Z","timestamp":1265420738000},"page":"1772-1778","source":"Crossref","is-referenced-by-count":4,"title":["From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"G.D.","family":"Aletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Nordquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gallenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Cliby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq025_bb0010","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq025_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0305-7372(86)90007-1","article-title":"Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity","volume":"13","author":"Markman","year":"1986","journal-title":"Cancer Treat Rev"},{"key":"10.1093\/annonc\/mdq025_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-8258(90)90099-7","article-title":"A review: intraperitoneal cisplatin in the management of patients with ovarian cancer","volume":"36","author":"McClay","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdq025_bb0025","first-page":"84","article-title":"Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer?","volume":"22","author":"Markman","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1093\/annonc\/mdq025_bb0030","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-97-6-845","article-title":"Intraperitoneal cispaltin with systemic thiosulfate protection","volume":"97","author":"Howell","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1093\/annonc\/mdq025_bb0035","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"10.1093\/annonc\/mdq025_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1006\/gyno.1994.1220","article-title":"A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer","volume":"54","author":"Kirmani","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdq025_bb0045","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq025_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000011980","article-title":"A comparative study of intraperitoneal carboplatin versus intravenous carboplatin with intravenous cyclophosphamide in both arms as initial chemotherapy for stage III ovarian cancer","volume":"56","author":"Polyzos","year":"1999","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdq025_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/gyno.1999.5677","article-title":"Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologica Nord-Ovest","volume":"76","author":"Gadducci","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdq025_bb0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0020-7292(00)00340-4","article-title":"Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer","volume":"72","author":"Yen","year":"2001","journal-title":"Int J Gynecol Obstet"},{"key":"10.1093\/annonc\/mdq025_bb0065","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdq025_bb0070","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ygyno.2007.02.015","article-title":"Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care","volume":"105","author":"Fung-Kee-Fung","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdq025_bb0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1634\/theoncologist.2007-0224","article-title":"Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view","volume":"13","author":"Vergote","year":"2008","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdq025_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq025_bb0085","unstructured":"National Cancer Institute. NCI Clinical Announcement: Intraperitoneal Chemotherapy for Ovarian Cancer, January 5, 2006. http:\/\/ctep.cancer.gov\/highlights\/docs\/clin_annc_010506.pdf. (30 January 2010, date last accessed)"},{"key":"10.1093\/annonc\/mdq025_bb0090","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1200\/JCO.2006.06.0376","article-title":"Intraperitoneal chemotherapy in ovarian cancer remains experimental","volume":"24","author":"Gore","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl 8","key":"10.1093\/annonc\/mdq025_bb0095","doi-asserted-by":"crossref","first-page":"viii13","DOI":"10.1093\/annonc\/mdi962","article-title":"Gynecologic Cancer Intergroup; GOG; NCIC-CTG; AGO-OVAR; ANZGOG; JGOG; GINECO; SGCTG; MRC\/NCRI; NSGO; RTOG; GEICO; EORTC. Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens","volume":"16","author":"Thigpen","year":"2005","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdq025_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ygyno.2006.06.026","article-title":"Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel","volume":"103","author":"Ozols","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdq025_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2009.04.001","article-title":"Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer","volume":"114","author":"Naumann","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdq025_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2008.12.035","article-title":"An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer","volume":"113","author":"Berry","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdq025_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2005.11.013","article-title":"Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"100","author":"Walker","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419400501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419400501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/9\/1772\/338786\/mdq025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T09:37:22Z","timestamp":1624700242000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419400501"}},"issued":{"date-parts":[[2010,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0923753419400501"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq025","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2010,9]]}},{"indexed":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T18:00:21Z","timestamp":1718820021689},"reference-count":0,"publisher":"Elsevier BV","issue":"suppl_9","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1093\/annonc\/mdw582.055","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T12:36:26Z","timestamp":1486125386000},"source":"Crossref","is-referenced-by-count":1,"title":["274TiP A randomized phase 2 study of nanoliposomal irinotecan (nal-IRI, BAX2398)-containing regimen in Japanese patients with metastatic pancreatic adenocarcinoma (mPAC)"],"prefix":"10.1016","volume":"27","author":[{"given":"T.","family":"Ioka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tokudome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2016,12,20]]},"container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/27\/suppl_9\/mdw582.055\/10241966\/mdw582.055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T12:48:07Z","timestamp":1577969287000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annonc\/article-lookup\/doi\/10.1093\/annonc\/mdw582.055"}},"issued":{"date-parts":[[2016,12]]},"references-count":0,"journal-issue":{"issue":"suppl_9","published-online":{"date-parts":[[2016,12,20]]},"published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdw582.055","ISSN":["0923-7534","1569-8041"],"issn-type":[{"value":"0923-7534","type":"print"},{"value":"1569-8041","type":"electronic"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:10:51Z","timestamp":1648746651780},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":8059,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,2]]},"DOI":"10.1093\/oxfordjournals.annonc.a010962","type":"journal-article","created":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T23:02:29Z","timestamp":1334790149000},"page":"127-128","source":"Crossref","is-referenced-by-count":0,"title":["Perhaps not everyone knows that\u2026"],"prefix":"10.1016","volume":"9","member":"78","reference":[{"issue":"13","key":"10.1093\/oxfordjournals.annonc.a010962_bb0010","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1093\/hmg\/6.13.2309","article-title":"Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: Evidence for additional susceptibility genes","author":"Vehmanen","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1093\/oxfordjournals.annonc.a010962_bb0015","doi-asserted-by":"crossref","first-page":"13203","DOI":"10.1073\/pnas.94.24.13203","article-title":"Loss of ovarian function promotes angiogenesis in human ovarian carcinoma","volume":"94","author":"Schiffenbauer","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1093\/oxfordjournals.annonc.a010962_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/gyno.1997.4844","article-title":"High frequency of BRCA1 and BRCA2 germline mutations in Ashkenazi Jewish ovarian cancer patients","volume":"67","author":"Beller","year":"1997","journal-title":"regardless of family history. Gynecol Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a010962_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/(SICI)1097-0215(19971104)73:3<367::AID-IJC11>3.0.CO;2-A","article-title":"Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent","volume":"73","author":"Ogawa","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a010962_bb0030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/37126","article-title":"Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance","volume":"390","author":"Boehm","year":"1997","journal-title":"Nature"},{"key":"10.1093\/oxfordjournals.annonc.a010962_bb0035","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1182\/blood.V90.11.4278","article-title":"Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma","volume":"90","author":"Said","year":"1997","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955342X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341955342X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/2\/127\/19481701\/9-2-127b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T17:16:58Z","timestamp":1582651018000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341955342X"}},"issued":{"date-parts":[[1998,2]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["S092375341955342X"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a010962","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[1998,2]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:16:25Z","timestamp":1720534585227},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":3354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1093\/annonc\/mdq561","type":"journal-article","created":{"date-parts":[[2010,10,25]],"date-time":"2010-10-25T09:38:04Z","timestamp":1287999484000},"page":"ix15-ix22","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S9","title":["Oral session 1"],"prefix":"10.1016","volume":"21","member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419396747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419396747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/suppl_9\/ix15\/24064292\/mdq561.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T05:00:54Z","timestamp":1592888454000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419396747"}},"issued":{"date-parts":[[2010,11]]},"references-count":0,"alternative-id":["S0923753419396747"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq561","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2010,11]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:17:38Z","timestamp":1720534658985},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":8030,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998]]},"DOI":"10.1093\/annonc\/9.suppl_2.v","type":"journal-article","created":{"date-parts":[[2012,4,5]],"date-time":"2012-04-05T23:02:23Z","timestamp":1333666943000},"page":"v","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["Preface"],"prefix":"10.1016","volume":"9","member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419617369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419617369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/suppl_2\/v\/6681898\/9-suppl_2-v.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:28:42Z","timestamp":1582248522000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419617369"}},"issued":{"date-parts":[[1998]]},"references-count":0,"alternative-id":["S0923753419617369"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/9.suppl_2.v","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[1998]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:15:46Z","timestamp":1720534546514},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":4876,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1093\/annonc\/mdl260","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T21:45:25Z","timestamp":1159911925000},"page":"x200-x206","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S10","title":["Biomarkers and screening for prostate cancer"],"prefix":"10.1016","volume":"17","author":[{"given":"F.H.","family":"Schr\u00f6der","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdl260_bb0010","first-page":"159","article-title":"Purification of a human prostate specific antigen","volume":"17","author":"Wang","year":"1979","journal-title":"Invest Urol"},{"key":"10.1093\/annonc\/mdl260_bb0015","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","article-title":"Measurement of prostate-specific antigen in serum as a screening test for prostate cancer","volume":"324","author":"Catalona","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl260_bb0020","series-title":"ICUD Prostate Cancer","first-page":"87","article-title":"Advances in Biomarkers for Prostate Disease","author":"Getzenberg","year":"2006"},{"key":"10.1093\/annonc\/mdl260_bb0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/03008880510030941","article-title":"Prognostic value of serum markers for prostate cancer","volume":"216","author":"Stenman","year":"2005","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1093\/annonc\/mdl260_bb0030","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/clinchem\/46.11.1855","article-title":"New nomenclature for the human tissue kallikrein gene family","volume":"46","author":"Diamandis","year":"2000","journal-title":"Clin Chem"},{"key":"10.1093\/annonc\/mdl260_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/pros.2990120106","article-title":"Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands","volume":"12","author":"Abrahamsson","year":"1988","journal-title":"Prostate"},{"key":"10.1093\/annonc\/mdl260_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/pros.2990120106","article-title":"Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands","volume":"12","author":"Abrahamsson","year":"1988","journal-title":"Prostate"},{"key":"10.1093\/annonc\/mdl260_bb0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0302-2838(02)00278-6","article-title":"Different PSA assays lead to detection of prostate cancers with identical histological features","volume":"42","author":"Yurdakul","year":"2002","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0050","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2005.04.015","article-title":"Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2\u201310 ng\/ml: systematic review and meta-analysis","volume":"48","author":"Roddam","year":"2005","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0055","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1373\/49.2.243","article-title":"Comparison of two assays for human kallikrein 2","volume":"49","author":"Blijenberg","year":"2003","journal-title":"Clin Chem"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mdl260_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-410X.2003.04389.x","article-title":"The story of the European Randomized Study of Screening for Prostate Cancer","volume":"92","author":"Schroder","year":"2003","journal-title":"BJU Int"},{"issue":"Suppl 6","key":"10.1093\/annonc\/mdl260_bb0065","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1016\/S0197-2456(00)00097-0","article-title":"The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status","volume":"21","author":"Gohagan","year":"2000","journal-title":"Control Clin Trials"},{"key":"10.1093\/annonc\/mdl260_bb0070","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/clinchem\/44.6.1216","article-title":"Novel immunoassay for the measurement of complexed prostate-specific antigen in serum","volume":"44","author":"Allard","year":"1998","journal-title":"Clin Chem"},{"key":"10.1093\/annonc\/mdl260_bb0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2005.04.015","article-title":"Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA Level of 2\u201310 ng\/ml: systematic review and meta-analysis","volume":"48","author":"Stephan","year":"2005","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0080","first-page":"5975","article-title":"DD3: a new prostate-specific gene, highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdl260_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","article-title":"DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer","volume":"44","author":"Hessels","year":"2003","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl260_bb0095","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl260_bb0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.294.1.66","article-title":"Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng\/ml or lower","volume":"294","author":"Thompson","year":"2005","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdl260_bb0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/(SICI)1097-0045(19990601)39:4<316::AID-PROS14>3.0.CO;2-O","article-title":"Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam region)","volume":"39","author":"Kranse","year":"1999","journal-title":"Prostate"},{"key":"10.1093\/annonc\/mdl260_bb0110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0090-4295(99)80342-2","article-title":"The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men","volume":"46","author":"Bangma","year":"1995","journal-title":"Urology"},{"key":"10.1093\/annonc\/mdl260_bb0115","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0022-5347(17)35233-3","article-title":"Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men","volume":"151","author":"Catalona","year":"1994","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mdl260_bb0120","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/jnci\/91.15.1331B","article-title":"Lest we abandon digital rectal examination as a screening test for prostate cancer","volume":"91","author":"Schr\u00f6der","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdl260_bb0125","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/jama.279.19.1542","article-title":"Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial","volume":"279","author":"Catalona","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1093\/annonc\/mdl260_bb0130","article-title":"Word of wisdom","author":"Schroder","year":"2006","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0135","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/pros.20352","article-title":"A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55\u201375 years using a biopsy indication of 3.0 ng\/ml (results of ERSPC, Rotterdam)","volume":"66","author":"Roobol","year":"2006","journal-title":"Prostate"},{"key":"10.1093\/annonc\/mdl260_bb0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa021659","article-title":"Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen","volume":"349","author":"Punglia","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl260_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMe030073","article-title":"Verification bias and the prostate-specific antigen test\u2014is there a case for a lower threshold for biopsy?","volume":"349","author":"Schroder","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl260_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0090-4295(00)00863-3","article-title":"Prostate-specific antigen-based early detection of prostate cancer\u2014validation of screening without rectal examination","volume":"57","author":"Schroder","year":"2001","journal-title":"Urology"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mdl260_bb0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1464-410X.2003.04390.x","article-title":"Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands)","volume":"92","author":"Roobol","year":"2003","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mdl260_bb0160","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jnci\/dji205","article-title":"Prostate-specific antigen levels in the United States: implications of various definitions for abnormal","volume":"97","author":"Welch","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdl260_bb0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.eururo.2005.12.069","article-title":"Prostate-specific antigen levels in the United States: implications of various definitions for abnormal","volume":"49","author":"Schr\u00f6der","year":"2006","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdl260_bb0175","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdl260_bb0180","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.eururo.2005.12.026","article-title":"Does PSA velocity predict prostate cancer in pre-screened populations?","volume":"49","author":"Schroder","year":"2006","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0185","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eururo.2005.12.028","article-title":"PSA velocity and prostate cancer detection: the absence of evidence is not the evidence of absence","volume":"49","author":"Perrin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0190","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1023\/A:1008492013196","article-title":"Overdiagnosis of prostate carcinoma by screening: an estimate based on the results of the Florence Screening Pilot Study","volume":"9","author":"Zappa","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl260_bb0195","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jnci\/94.13.981","article-title":"Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends","volume":"94","author":"Etzioni","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdl260_bb0200","first-page":"1368","article-title":"Screening for prostate cancer: estimating the magnitude of overdetection","volume":"159","author":"McGregor","year":"1998","journal-title":"CMAJ"},{"key":"10.1093\/annonc\/mdl260_bb0205","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/jnci\/95.12.868","article-title":"Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer","volume":"95","author":"Draisma","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdl260_bb0210","series-title":"Tumor features of second screening round detected prostate cancers warrant increased choice for watchful waiting","author":"Postma","year":"2006"},{"key":"10.1093\/annonc\/mdl260_bb0215","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.ju.0000094764.56269.2d","article-title":"Comparison of Cox regression with other methods for determining prediction models and nomograms","volume":"170","author":"Kattan","year":"2003","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mdl260_bb0220","article-title":"Prediction of indolent prostate cancer. Validation and updating of a prognostic nomogram","author":"Steyerberg","year":"2006","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mdl260_bb0225","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/S0022-5347(01)62200-6","article-title":"Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free\/total prostate specific antigen levels and needle biopsy findings","volume":"160","author":"Epstein","year":"1998","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mdl260_bb0230","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0090-4295(02)01875-7","article-title":"Prostate-specific antigen cutoff of 2.6 ng\/mL for prostate cancer screening is associated with favorable pathologic tumor features","volume":"60","author":"Krumholtz","year":"2002","journal-title":"Urology"},{"key":"10.1093\/annonc\/mdl260_bb0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0302-2838(03)00139-8","article-title":"Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative prediction","volume":"43","author":"Augustin","year":"2003","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mdl260_bb0240","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1464-410X.2003.04657.x","article-title":"Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of < 4.0 ng\/mL","volume":"93","author":"Sokoloff","year":"2004","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mdl260_bb0245","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncpuro0124","article-title":"Active surveillance with selective delayed intervention is the way to manage \u2018good-risk\u2019 prostate cancer","volume":"2","author":"Klotz","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"10.1093\/annonc\/mdl260_bb0250","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jnci\/djj072","article-title":"Delayed versus immediate surgical intervention and prostate cancer outcome","volume":"98","author":"Warlick","year":"2006","journal-title":"J Natl Cancer Inst"}],"container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419636872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419636872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/suppl_10\/x201\/403763\/mdl260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:25:36Z","timestamp":1589441136000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419636872"}},"issued":{"date-parts":[[2006,9]]},"references-count":49,"alternative-id":["S0923753419636872"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl260","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2006,9]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:18:29Z","timestamp":1720534709542},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":2046,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1093\/annonc\/mdu165.30","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T07:19:16Z","timestamp":1403075956000},"page":"ii23","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S2","title":["Novel Mechanism of Wnt Signalling Activation Mediated by DICKKOPF-1 Methylation in Pancreatic Cancer"],"prefix":"10.1016","volume":"25","author":[{"given":"Xu","family":"Qinhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duan","family":"Wanxing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Jianjun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma","family":"Qingyong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419360429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419360429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/25\/suppl_2\/ii23\/376769\/mdu165.30.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T07:05:36Z","timestamp":1589267136000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419360429"}},"issued":{"date-parts":[[2014,6]]},"references-count":0,"alternative-id":["S0923753419360429"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdu165.30","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[2014,6]]}},{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T14:22:48Z","timestamp":1720534968010},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":10234,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1992]]},"DOI":"10.1093\/annonc\/3.suppl_1.199","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T21:52:08Z","timestamp":1353361928000},"page":"199-216","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Authors index"],"prefix":"10.1016","volume":"3","member":"78","container-title":["Annals of Oncology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419627018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419627018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/3\/suppl_1\/199\/6678028\/3-suppl_1-199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:49:42Z","timestamp":1582249782000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419627018"}},"issued":{"date-parts":[[1992]]},"references-count":0,"alternative-id":["S0923753419627018"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/3.suppl_1.199","ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"published":{"date-parts":[[1992]]}}],"items-per-page":20,"query":{"start-index":0,"search-terms":null}}}